There are many ways to affect PD-L1 expression in cells, and a small molecule compound may only affect PD-L1 expression in one regulatory way, which also leads to the possibility that the compound may only be effective on this type of tumor cell; therefore, in future clinical applications, there are certain limitations. Here, CD274 is linked to neoplasm.